Kura Oncology, Inc. (KURA) stock
KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.34−0.15 (-2.00%)
Close on Nov 18, 2026Market cap $652.97MP/E –Yield –
Kura Oncology gross margin
Gross margin is gross profit as a percentage of revenue.
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 98.4% | – |
| Q2 FY2026 | Jun 30, 2026 | 98.8% | – |
| Q1 FY2026 | Mar 31, 2026 | 98.6% | – |
See a number that looks wrong?